GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,485.60p
   
  • Change Today:
      24.60p
  • 52 Week High: 2,263.00
  • 52 Week Low: 1,296.00
  • Currency: UK Pounds
  • Shares Issued: 4,094.68m
  • Volume: 7,774,368
  • Market Cap: £60,831m
  • RiskGrade: 129

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
1.07% above the market average1.07% above the market average1.07% above the market average1.07% above the market average1.07% above the market average
25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average
1yr Revenue Growth
3.15% below the market average3.15% below the market average3.15% below the market average3.15% below the market average3.15% below the market average
10.53% below the sector average10.53% below the sector average10.53% below the sector average10.53% below the sector average10.53% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
9.99% below the market average9.99% below the market average9.99% below the market average9.99% below the market average9.99% below the market average
75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average
1yr DPS Growth
93.2% below the market average93.2% below the market average93.2% below the market average93.2% below the market average93.2% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
19.49% below the market average19.49% below the market average19.49% below the market average19.49% below the market average19.49% below the market average
51.52% below the sector average51.52% below the sector average51.52% below the sector average51.52% below the sector average51.52% below the sector average
Price Book Ratio
82.8% below the market average82.8% below the market average82.8% below the market average82.8% below the market average82.8% below the market average
60.71% below the sector average60.71% below the sector average60.71% below the sector average60.71% below the sector average60.71% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
12.65% above the market average12.65% above the market average12.65% above the market average12.65% above the market average12.65% above the market average
16.13% above the sector average16.13% above the sector average16.13% above the sector average16.13% above the sector average16.13% above the sector average
Price Chg 3m
8.32% below the market average8.32% below the market average8.32% below the market average8.32% below the market average8.32% below the market average
29.03% above the sector average29.03% above the sector average29.03% above the sector average29.03% above the sector average29.03% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
15.22% above the market average15.22% above the market average15.22% above the market average15.22% above the market average15.22% above the market average
34.48% above the sector average34.48% above the sector average34.48% above the sector average34.48% above the sector average34.48% above the sector average
Momentum 20
77.44% above the market average77.44% above the market average77.44% above the market average77.44% above the market average77.44% above the market average
82.76% above the sector average82.76% above the sector average82.76% above the sector average82.76% above the sector average82.76% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
35.68% above the market average35.68% above the market average35.68% above the market average35.68% above the market average35.68% above the market average
79.49% above the sector average79.49% above the sector average79.49% above the sector average79.49% above the sector average79.49% above the sector average
ROCE
79.10% above the market average79.10% above the market average79.10% above the market average79.10% above the market average79.10% above the market average
87.50% above the sector average87.50% above the sector average87.50% above the sector average87.50% above the sector average87.50% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
90.01% above the market average90.01% above the market average90.01% above the market average90.01% above the market average90.01% above the market average
92.98% above the sector average92.98% above the sector average92.98% above the sector average92.98% above the sector average92.98% above the sector average
Forecast EPS
89.55% above the market average89.55% above the market average89.55% above the market average89.55% above the market average89.55% above the market average
80.00% above the sector average80.00% above the sector average80.00% above the sector average80.00% above the sector average80.00% above the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
97.66% above the market average97.66% above the market average97.66% above the market average97.66% above the market average97.66% above the market average
95.00% above the sector average95.00% above the sector average95.00% above the sector average95.00% above the sector average95.00% above the sector average
Operating Profit Loss
98.71% above the market average98.71% above the market average98.71% above the market average98.71% above the market average98.71% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
97.20% above the market average97.20% above the market average97.20% above the market average97.20% above the market average97.20% above the market average
96.36% above the sector average96.36% above the sector average96.36% above the sector average96.36% above the sector average96.36% above the sector average
Cash
97.12% above the market average97.12% above the market average97.12% above the market average97.12% above the market average97.12% above the market average
96.55% above the sector average96.55% above the sector average96.55% above the sector average96.55% above the sector average96.55% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
84.62% above the market average84.62% above the market average84.62% above the market average84.62% above the market average84.62% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Buys 1y
94.51% above the market average94.51% above the market average94.51% above the market average94.51% above the market average94.51% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
87.01% below the market average87.01% below the market average87.01% below the market average87.01% below the market average87.01% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Brokers Percent Neutral
64.79% above the market average64.79% above the market average64.79% above the market average64.79% above the market average64.79% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,485.60p
Change Today 24.60p
% Change 1.68 %
52 Week High 2,263.00
52 Week Low 1,296.00
Volume 7,774,368
Shares Issued 4,094.68m
Market Cap £60,831m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
58.29% below the market average58.29% below the market average58.29% below the market average58.29% below the market average58.29% below the market average
82.76% above the sector average82.76% above the sector average82.76% above the sector average82.76% above the sector average82.76% above the sector average
Price Trend
40.31% below the market average40.31% below the market average40.31% below the market average40.31% below the market average40.31% below the market average
25.81% above the sector average25.81% above the sector average25.81% above the sector average25.81% above the sector average25.81% above the sector average
Income
67.69% above the market average67.69% above the market average67.69% above the market average67.69% above the market average67.69% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
51.89% below the market average51.89% below the market average51.89% below the market average51.89% below the market average51.89% below the market average
75% below the sector average75% below the sector average75% below the sector average75% below the sector average75% below the sector average

What The Brokers Say

Strong Buy 2
Buy 6
Neutral 14
Sell 1
Strong Sell 2
Total 25
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q4 Q3
Ex-Div 23-Feb-23 17-Nov-22
Paid 13-Apr-23 12-Jan-23
Amount 13.75p 13.75p

Trades for 07-Feb-2023

Time Volume / Share Price
16:45 153 @ 1,485.40p
16:45 153 @ 1,485.40p
16:45 6,466 @ 1,485.40p
16:45 6,466 @ 1,485.40p
16:35 1,000 @ 1,485.60p

GSK Key Personnel

CEO Emma Walmsley
CFO Iain Mackay

Top of Page